– Data Covid-19 USA – Scarce supplies and surging Covid cases have caused health officials, hospitals, doctors and patients to scramble for pills and infusions.
– Data Covid-19 USA – People with compromised immune systems are getting unapproved fourth or fifth Covid-19 shots, despite uncertainty about their safety or effectiveness.
In the lab, antibodies produced during an Omicron infection protected against Delta. If Omicron dominates in the real world, that could lead to a less dire future.
The single remaining monoclonal antibody therapy effective against the variant is now in short supply in the U.S., imperiling an option that doctors and hospitals have relied on.
A 50-microgram dose increased antibodies by roughly 37-fold, and a full dose of 100 micrograms was even more powerful, the company said.
In the lab, immune cells put up a strong fight against Omicron, suggesting that vaccines will be able to prevent the worst outcomes of the virus variant.
In just a few weeks since its discovery, Omicron has turned out to be highly transmissible and less susceptible to vaccines than other variants.
The company’s finding is based on only a small study of blood samples in a laboratory, but others are sure to follow.
In a comparison of seven different brands, researchers found that most shots give a strong boost, even in mix-and-match combinations.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
- Nach der Ampelklausur: Wie Scholz auf Fragen nicht antwortet Nach der ersten Klausurtagung der Ampelkoalition haben die Journalisten eine Menge Fragen. Beantwortet wird kaum eine davon, und wenn, dann von Habeck oder Lindner. Erst am Schluss wird Bundeskanzler Scholz etwas konkreter.